Back to Search
ROBERT LASSER, MD
MD
Psychiatry Physician
NPI: 1376765958Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
ML1143419A(MA)
Research & Publications (20)
Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injection.
PMID 15908183·Schizophr Res·2005
3-trial
Efficacy and safety of long-acting risperidone in stable patients with schizoaffective disorder.
PMID 15555724·J Affect Disord·2004
3-trial
Smokers and nonsmokers equally affected by olanzapine-induced weight gain: metabolic implications.
PMID 15061249·Schizophr Res·2004
3-trial
Oscillations of Hes7 caused by negative autoregulation and ubiquitination.
PMID 17983837·Comput Biol Chem·2008
7-preclinical
Remission in schizophrenia: applying recent consensus criteria to refine the concept.
PMID 17765480·Schizophr Res·2007
8-other
Evaluation of a treatment manual for risperidone long-acting injectable.
PMID 17345148·Community Ment Health J·2007
8-other
Maintenance therapy with once-monthly administration of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder: a pilot study of an extended dosing interval.
PMID 17261186·Ann Gen Psychiatry·2007
8-other
Patient-based and clinician-based support for the remission criteria in schizophrenia.
PMID 17159460·Int Clin Psychopharmacol·2007
3-trial
Improving patient outcomes in schizophrenia: achieving remission.
PMID 17046987·J Psychopharmacol·2006
6-review
A 1-year double-blind study of 2 doses of long-acting risperidone in stable patients with schizophrenia or schizoaffective disorder.
PMID 16965196·J Clin Psychiatry·2006
4-observational
The concepts of remission and recovery in schizophrenia.
PMID 16944406·Pharmacopsychiatry·2006
6-review
Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation.
PMID 16760927·Neuropsychopharmacology·2006
4-observational
Insight and its relationship to clinical outcomes in patients with schizophrenia or schizoaffective disorder receiving long-acting risperidone.
PMID 16687995·Int Clin Psychopharmacol·2006
8-other
Methodological issues in a comparative study of ziprasidone and risperidone.
PMID 16426103·J Clin Psychiatry·2006
4-observational
Measuring remission in schizophrenia: response to Sethuraman et al., 2005.
PMID 16423505·Schizophr Res·2006
8-other
Minimal injection site pain and high patient satisfaction during treatment with long-acting risperidone.
PMID 15933482·Int Clin Psychopharmacol·2005
3-trial
Lack of impact of race on the efficacy and safety of long-acting risperidone versus placebo in patients with schizophrenia or schizoaffective disorder.
PMID 15933481·Int Clin Psychopharmacol·2005
3-trial
Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): cross-scale comparison in assessing tardive dyskinesia.
PMID 15913963·Schizophr Res·2005
4-observational
An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study.
PMID 15913962·Schizophr Res·2005
3-trial
Clinical improvement in 336 stable chronically psychotic patients changed from oral to long-acting risperidone: a 12-month open trial.
PMID 15804371·Int J Neuropsychopharmacol·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8 BOARDMAN AVE
MANCHESTER, MA 01944 - Phone
- (617) 387-8701
Quick Facts
- NPI
- 1376765958
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile